Literature DB >> 12081838

Body composition in children with sickle cell disease.

Elizabeth M Barden1, Deborah A Kawchak, Kwaku Ohene-Frempong, Virginia A Stallings, Babette S Zemel.   

Abstract

BACKGROUND: Impaired growth, poor nutritional status, and delayed skeletal and sexual maturation are common in children with sickle cell disease (SCD), yet the nature of associated body-composition deficits has not been fully described.
OBJECTIVE: The objective was to assess growth, nutritional status, and body composition in 36 African American children with type SS SCD (20 females and 16 males) and 30 healthy control children (15 females and 15 males) of similar age (5-18 y) and ethnicity.
DESIGN: Height, weight, bone age, pubertal status, skinfold thickness, and arm circumference were assessed. Height and weight were converted to z scores by comparison with national reference data and skinfold-thickness measurements were converted to z scores by comparison with African American- specific reference data. Fat-free mass (FFM) and fat mass (FM) were estimated by using 4 methods. Prepubertal children, pubertal males, and pubertal females were analyzed separately.
RESULTS: Relative to the control subjects and to a national sample, children with SCD had significantly lower z scores for weight, height, arm circumference, and upper arm fat and muscle areas. Relative skeletal maturation was significantly delayed. After adjustment for age, children with SCD had significantly lower FM (prepubertal children and pubertal males only) and FFM (all 3 groups).
CONCLUSIONS: Children with SCD have impaired growth, delayed puberty, and poor nutritional status. Low z scores for upper arm fat area indicate deficits in fat (energy) stores, and low FFM coupled with low upper arm muscle area indicate muscle wasting and low protein stores. These body-composition abnormalities suggest that the nutritional needs of the African American children with SCD were not being met.

Entities:  

Mesh:

Year:  2002        PMID: 12081838     DOI: 10.1093/ajcn/76.1.218

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  28 in total

1.  Hydroxyurea and growth in young children with sickle cell disease.

Authors:  Sohail Rana; Patricia E Houston; Winfred C Wang; Rathi V Iyer; Jonathan Goldsmith; James F Casella; Caroline K Reed; Zora R Rogers; Myron A Waclawiw; Bruce Thompson
Journal:  Pediatrics       Date:  2014-09       Impact factor: 7.124

2.  Muscle Strength, Power, and Torque Deficits in Children With Type SS Sickle Cell Disease.

Authors:  Kelly A Dougherty; Chiara Bertolaso; Joan I Schall; Kim Smith-Whitley; Virginia A Stallings
Journal:  J Pediatr Hematol Oncol       Date:  2018-07       Impact factor: 1.289

3.  Brain volume in pediatric patients with sickle cell disease: evidence of volumetric growth delay?

Authors:  R Grant Steen; Temitope Emudianughe; Michael Hunte; John Glass; Shengjie Wu; Xiaoping Xiong; Wilburn E Reddick
Journal:  AJNR Am J Neuroradiol       Date:  2005-03       Impact factor: 3.825

4.  Sleep Problem Risk for Adolescents With Sickle Cell Disease: Sociodemographic, Physical, and Disease-related Correlates.

Authors:  Cecelia R Valrie; Krystal L Trout; Kayzandra E Bond; Rebecca J Ladd; Nichelle L Huber; Kristen J Alston; Alicia M Sufrinko; Erik Everhart; Beng R Fuh
Journal:  J Pediatr Hematol Oncol       Date:  2018-03       Impact factor: 1.289

5.  Attenuated maximal muscle strength and peak power in children with sickle cell disease.

Authors:  Kelly A Dougherty; Joan I Schall; Alisha J Rovner; Virginia A Stallings; Babette S Zemel
Journal:  J Pediatr Hematol Oncol       Date:  2011-03       Impact factor: 1.289

6.  Height-corrected low bone density associates with severe outcomes in sickle cell disease: SCCRIP cohort study results.

Authors:  Oyebimpe O Adesina; James G Gurney; Guolian Kang; Martha Villavicencio; Jason R Hodges; Wassim Chemaitilly; Sue C Kaste; Babette S Zemel; Jane S Hankins
Journal:  Blood Adv       Date:  2019-05-14

7.  Longitudinal differences in aerobic capacity between children with sickle cell anemia and matched controls.

Authors:  Andrew M Watson; Robert I Liem; Zengqi Lu; Ben Saville; Sari Acra; Sadhna Shankar; Maciej Buchowski
Journal:  Pediatr Blood Cancer       Date:  2014-12-31       Impact factor: 3.167

8.  Genetic polymorphism of APOB is associated with diabetes mellitus in sickle cell disease.

Authors:  Xu Zhang; Wei Zhang; Santosh L Saraf; Mehdi Nouraie; Jin Han; Michel Gowhari; Johara Hassan; Galina Miasnikova; Adelina Sergueeva; Sergei Nekhai; Rick Kittles; Roberto F Machado; Joe G N Garcia; Mark T Gladwin; Martin H Steinberg; Paola Sebastiani; Donald A McClain; Victor R Gordeuk
Journal:  Hum Genet       Date:  2015-05-30       Impact factor: 4.132

9.  Safety and Efficacy of High-dose Daily Vitamin D3 Supplementation in Children and Young Adults With Sickle Cell Disease.

Authors:  Kelly A Dougherty; Chiara Bertolaso; Joan I Schall; Kim Smith-Whitley; Virginia A Stallings
Journal:  J Pediatr Hematol Oncol       Date:  2015-07       Impact factor: 1.289

10.  Age at diagnosis of sickle cell anaemia in lagos, Nigeria.

Authors:  So Akodu; In Diaku-Akinwumi; Of Njokanma
Journal:  Mediterr J Hematol Infect Dis       Date:  2013-01-02       Impact factor: 2.576

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.